The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma-Reference-Cited by-同舟云学术

The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma

Published:2015-11-29 Issue:2 Volume:7 Page:1500-1515
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Passaro Carmela¹,Borriello Francesco¹²,Vastolo Viviana¹,Di Somma Sarah¹,Scamardella Eloise¹,Gigantino Vincenzo³,Franco Renato⁴,Marone Gianni¹²³,Portella Giuseppe¹

Affiliation:

1. Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy

2. Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy

3. CNR Institute of Experimental Endocrinology and Oncology “G. Salvatore”, Naples, Italy

4. Experimental Oncology, IRCCS Fondazione Pascale, Naples, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy;Clinical and Experimental Medicine;2024-08-28

2. Research progress of immunotherapy against anaplastic thyroid cancer;Frontiers in Oncology;2024-03-26

3. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug;Biomedicine & Pharmacotherapy;2024-01

4. New Insights into Immune Cells and Immunotherapy for Thyroid Cancer;Immunological Investigations;2023-10-17

5. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers;Cancer Immunology, Immunotherapy;2023-10-05